Trichomoniasis comes back in about 1 in 5 people within three months of treatment. That’s a surprisingly high number for an infection with a known cure, and it leaves many people frustrated and wondering what they’re doing wrong. The answer usually comes down to one of three things: reinfection from an untreated partner, the parasite surviving in hard-to-reach areas of the body, or, less commonly, resistance to the medication itself.
Untreated Partners Are the Most Common Cause
The single biggest reason trichomoniasis keeps returning is what doctors call the “ping-pong effect.” You get treated, you feel better, you resume sexual activity, and your partner, who was never treated or didn’t finish treatment, passes the same infection right back to you. This cycle can repeat indefinitely.
The parasite that causes trichomoniasis often produces no symptoms at all, especially in men. Most men who carry it have no idea they’re infected, which means they have no reason to seek treatment on their own. Meanwhile, they remain capable of transmitting the infection every time they have sex. Even partners who were told to get treated may not follow through. Studies on giving partners medication directly (rather than asking them to visit a clinic) show that patients whose partners received treatment this way were 29% less likely to get reinfected. That gap tells you how often partners simply don’t get treated when left to arrange it themselves.
Both partners need to complete their full course of medication, and you should avoid sex for at least a week after both of you finish treatment. Skipping this waiting period is another common way the infection bounces back before either person has fully cleared it.
The Parasite Can Hide in the Body
Even when your partner is treated, the parasite itself can sometimes survive in places where medication doesn’t reach full concentration. In women, it can colonize glands around the urethra and vaginal opening. In men, the prostate is a particular concern. Trichomonas vaginalis has been found in prostate tissue, in the urine of men with prostatitis, and even in tissue from men with benign prostate enlargement. Most of these men had no symptoms, which means the infection can persist quietly for months or longer.
The prostate creates a low-oxygen environment that differs from the vagina, and while fewer parasites survive there, the ones that do can be difficult to eliminate with a standard short course of antibiotics. This is one reason a single dose of medication may not always be enough, and why some providers now recommend a longer, multi-day course for certain patients.
Bacteria Living Inside the Parasite
Trichomonas vaginalis can harbor a smaller organism called Mycoplasma hominis inside its own cells. This bacterium essentially hitches a ride within the parasite, using it as a shield against both the immune system and antibiotics. Research has shown that bacteria living inside the parasite develop reduced sensitivity to certain antibiotics compared to the same bacteria found on their own. While this relationship doesn’t directly cause your trichomoniasis to return, it can complicate treatment by creating a reservoir of co-infection that is harder to fully eliminate.
Medication Resistance Is Real but Uncommon
The standard treatment for trichomoniasis belongs to a class of drugs called nitroimidazoles. Somewhere between 4% and 10% of trichomoniasis cases show some degree of resistance to these medications. A CDC surveillance study that tested over 500 samples from across the United States found that 4.3% showed low-level resistance. None of those samples showed moderate or high-level resistance, which is reassuring but doesn’t mean treatment failure can’t happen.
Low-level resistance typically means the standard single-dose treatment might not work, but a longer course at a higher dose usually will. True high-level resistance, where alternative approaches are needed, remains rare. If you’ve been treated more than once and tested positive again without a clear source of reinfection, medication resistance is worth discussing with your provider. There are alternative dosing strategies and, in some cases, different medications that can overcome resistant strains.
HIV Status Affects Recurrence Risk
People living with HIV face a notably higher risk of trichomoniasis coming back. In one study, 18.3% of HIV-positive women tested positive for the parasite just one month after treatment, compared to 8% of HIV-negative women. Among HIV-positive women specifically, repeat infection rates have been reported as high as 30%.
A weakened immune system makes it harder to fully clear the parasite, and treatment failure rates at one month were elevated in both groups (10% for HIV-positive women, 7.3% for HIV-negative women). If you’re living with HIV, your provider may recommend a longer initial treatment course and closer follow-up testing to catch any recurrence early.
Getting Retested at the Right Time
Timing matters when it comes to confirming the infection is truly gone. The CDC recommends retesting three months after treatment. Testing too early, within the first few weeks, can sometimes pick up dead parasite DNA and give a false positive result on certain types of tests. Waiting the full three months also gives enough time for a genuine reinfection to show up if your partner wasn’t adequately treated.
If you’ve had trichomoniasis once, you should plan on that three-month retest even if you feel completely fine. Many repeat infections cause no symptoms at all, particularly in the early weeks. Catching a recurrence early matters because untreated trichomoniasis increases susceptibility to other sexually transmitted infections and can cause complications during pregnancy.
How to Break the Cycle
If trichomoniasis keeps coming back, work through the most likely explanations in order. First, confirm that every sexual partner has been treated, ideally at the same time as you. If your partner says they were treated but you have no way to verify it, that remains the most probable source of reinfection. Second, ask your provider about a longer treatment course rather than a single dose, especially if you’ve already had one recurrence. Third, use condoms consistently during and after treatment. Condoms significantly reduce transmission of the parasite, though they don’t eliminate risk entirely since the parasite can live on skin areas not covered by a condom.
If you’ve addressed all of these factors and still test positive, your provider can request sensitivity testing on a sample of the parasite to check for drug resistance. This testing isn’t routine, but it’s available and can guide a more targeted treatment plan. The vast majority of recurrent trichomoniasis cases resolve once the true underlying cause, usually an untreated partner, is identified and addressed.